Drugs / Autologous differentiated myocytes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07426068 | Jul 2026 → Feb 2028 expected | metabolic disease, muscular atrophy | National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous differentiated myocytes | “Autologous differentiated myocytes will be prepared from each participant and transplanted subcutaneously.” NCT07426068 ↗ |
| Route | Subcutaneous | “transplanted subcutaneously” NCT07426068 ↗ |